Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Somatropin - Genentech

Drug Profile

Somatropin - Genentech

Alternative Names: Nutrophin; Nutropin; Nutropin Aq; NutropinAq; SMP 140

Latest Information Update: 23 Jan 2019

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Genentech
  • Developer Dainippon Sumitomo Pharma; Genentech; Ipsen; Roche
  • Class Growth hormones; Hormonal replacements; Obesity therapies
  • Mechanism of Action Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Somatotropin deficiency
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Short stature; Somatotropin deficiency; Turner's syndrome
  • No development reported Fibromyalgia

Most Recent Events

  • 08 Jan 2019 Genentech and University of Texas Southwestern Medical Center withdraws a phase II/III trial in HIV infection (In children) in USA prior to enrolment (SC) (NCT00256555)
  • 25 Dec 2018 Genentech and University of Texas Southwestern Medical Center withdraw a phase II/III trial in HIV infection in USA prior to enrolment (NCT00286676)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Somatotropin-deficiency in European Union (SC, Controlled release)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top